- AU$240.43m
- AU$362.06m
- AU$308.01m
- 92
- 68
- 91
- 96
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 17.73 | ||
PEG Ratio (f) | 0.76 | ||
EPS Growth (f) | 30.38% | ||
Dividend Yield (f) | 3.61% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.96 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.76 | ||
EV to EBITDA | 10.7 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.24% | ||
Return on Equity | 4.19% | ||
Operating Margin | 7.31% |
Financial Summary
Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 236.58 | 231.88 | 235.86 | 237.75 | 308.01 | 324.9 | 348.4 | 21.27% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -51.7 | n/a | n/a | +2.96 | +12.85 | -25.07 | +40 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Paragon Care Limited is an Australia-based company. It is engaged in the supply of durable medical equipment, medical devices and consumable medical products and maintenance of technical medical equipment to the health, aged care and veterinary markets throughout Australia. Its segments include Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology. Diagnostic and Scientific segment incorporates blood bank diagnostics manufacturer, clinical pathology diagnostics distribution and scientific and research and development (R&D) laboratory equipment distribution. Devices Segment incorporates ophthalmology and optometry, orthopedics, pain management, infection prevention and ortho biologics. Capital and Consumables segment includes medical, surgical and veterinary services. Service and Technology segment includes offering from biomedical devices to high end capital equipment, service support and technology management and service partnership with brands.
Directors
- Shane Tanner NEC
- Phil Nicholl CEO
- Stephen Munday CFO (54)
- Michael Rice OTH (41)
- Melanie Leydin SEC
- Mark Simari NED (50)
- Geoffrey Sam NID (65)
- Brent Stewart NID
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 3rd, 1994
- Public Since
- October 15th, 1999
- No. of Shareholders
- 6,245
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 667,868,179
- Address
- Level 4, 96-100 Albert Road, SOUTH MELBOURNE, 3205
- Web
- https://paragoncare.com.au/contact
- Phone
- +61 300369559
- Auditors
- RSM Australia Partners
Upcoming Events for PGC
Full Year 2024 Paragon Care Ltd Earnings Release
Similar to PGC
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:16 UTC, shares in Paragon Care are trading at AU$0.36. This share price information is delayed by 15 minutes.
Shares in Paragon Care last closed at AU$0.36 and the price had moved by +44% over the past 365 days. In terms of relative price strength the Paragon Care share price has outperformed the ASX All Ordinaries Index by +31.22% over the past year.
The overall consensus recommendation for Paragon Care is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Paragon Care dividend yield is 1.67% based on the trailing twelve month period.
Last year, Paragon Care paid a total dividend of AU$0.01, and it currently has a trailing dividend yield of 1.67%. We do not have any data on when Paragon Care is to next pay dividends.
We do not have data on when Paragon Care is to next pay dividends. The historic dividend yield on Paragon Care shares is currently 1.67%.
To buy shares in Paragon Care you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.36, shares in Paragon Care had a market capitalisation of AU$240.43m.
Here are the trading details for Paragon Care:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: PGC
Based on an overall assessment of its quality, value and momentum Paragon Care is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Paragon Care is AU$0.31. That is 13.89% below the last closing price of AU$0.36.
Analysts covering Paragon Care currently have a consensus Earnings Per Share (EPS) forecast of AU$0.02 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Paragon Care. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +73.55%.
As of the last closing price of AU$0.36, shares in Paragon Care were trading +56.95% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Paragon Care PE ratio based on its reported earnings over the past 12 months is 17.73. The shares last closed at AU$0.36.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Paragon Care's management team is headed by:
- Shane Tanner - NEC
- Phil Nicholl - CEO
- Stephen Munday - CFO
- Michael Rice - OTH
- Melanie Leydin - SEC
- Mark Simari - NED
- Geoffrey Sam - NID
- Brent Stewart - NID